Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).

Vaccine - 16 Aug 2010

Goulleret Nicolas, Mauvisseau Elodie, Essevaz-Roulet Mélanie, Quinlivan Mark, Breuer Judy

Abstract excerpt

BACKGROUND: VARIVAX (Oka/Merck) is a live varicella vaccine, licensed in Europe since 2003. In addition to routine safety surveillance, the Varicella Zoster Virus Identification Program (VZVIP) analyzes clinical samples to establish whether adverse events (AEs) are associated with wild-type (wt)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chickenpox
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Europe

Share to Herpes Zoster

Share to Herpesvirus 3, Human

Share to Infant

Share to Molecular Epidemiology

Source

Identifiers

PMID: 20600487
DOI: 10.1016/j.vaccine.2010.06.056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20600487-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).PMID 20600487Read ↗

Epidemiology and clinical profile of herpes zoster in the varicella vaccine era: A case series studySemantic proximity Read ↗

Complete DNA Sequences of Two Oka Strain Varicella-Zoster Virus GenomesSemantic proximity Read ↗

Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.Semantic proximity Read ↗

Severe and Complicated Varicella and Associated Genotypes 10 Years After Introduction of a One-Dose Varicella Vaccine Program.Semantic proximity Read ↗

Clinical and molecular aspects of the live attenuated Oka varicella vaccineSemantic proximity Read ↗

Molecular studies of the Oka varicella vaccine.Semantic proximity Read ↗

Vaccine Oka variants and sequence variability in vaccine-related skin lesions.Semantic proximity Read ↗

[The genotyping and molecular evolution of varicella-zoster virus].Semantic proximity Read ↗

Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.Semantic proximity Read ↗

Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR.Semantic proximity Read ↗

Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms.Semantic proximity Read ↗

Evolution and world-wide distribution of varicella-zoster virus clades.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.